GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tchaikapharma Highquality Medicines AD (XBUL:THQM) » Definitions » Interest Expense

Tchaikapharma Highquality Medicines AD (XBUL:THQM) Interest Expense : лв-0.59 Mil (TTM As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Tchaikapharma Highquality Medicines AD Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Tchaikapharma Highquality Medicines AD's interest expense for the three months ended in Mar. 2024 was лв -0.15 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was лв-0.59 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Tchaikapharma Highquality Medicines AD's Operating Income for the three months ended in Mar. 2024 was лв 1.95 Mil. Tchaikapharma Highquality Medicines AD's Interest Expense for the three months ended in Mar. 2024 was лв -0.15 Mil. Tchaikapharma Highquality Medicines AD's Interest Coverage for the quarter that ended in Mar. 2024 was 12.89. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Tchaikapharma Highquality Medicines AD Interest Expense Historical Data

The historical data trend for Tchaikapharma Highquality Medicines AD's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tchaikapharma Highquality Medicines AD Interest Expense Chart

Tchaikapharma Highquality Medicines AD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial -0.22 -0.24 -0.27 -0.28 -0.55

Tchaikapharma Highquality Medicines AD Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.11 -0.13 -0.15 -0.16 -0.15

Tchaikapharma Highquality Medicines AD Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was лв-0.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tchaikapharma Highquality Medicines AD  (XBUL:THQM) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Tchaikapharma Highquality Medicines AD's Interest Expense for the three months ended in Mar. 2024 was лв-0.15 Mil. Its Operating Income for the three months ended in Mar. 2024 was лв1.95 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was лв0.69 Mil.

Tchaikapharma Highquality Medicines AD's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2024 )/Interest Expense (Q: Mar. 2024 )
=-1*1.946/-0.151
=12.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Tchaikapharma Highquality Medicines AD (XBUL:THQM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tchaikapharma Highquality Medicines AD (XBUL:THQM) » Definitions » Interest Expense
Comparable Companies
KAR:LOADS KAR:PIM KAR:ORM KAR:LSEPL KAR:HCL KAR:AKDSL KAR:KPUS KAR:OCTOPUS KAR:FTMM KAR:PTL ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
1 G. M. Dimitrov Boulevard, Sofia, BGR, 1172
Website
https://www.tchaikapharma.com
Tchaikapharma Highquality Medicines AD is engaged in the business of manufacturing and selling pharmaceuticals in Bulgaria. It manufactures medicines for cancer, heart diseases, respiratory problems, and neurological diseases, among others.

Tchaikapharma Highquality Medicines AD (XBUL:THQM) Headlines

No Headlines